Boflox flavour 20 mg tablets for dogs and cats

国家: 爱尔兰

语言: 英文

来源: HPRA (Health Products Regulatory Authority)

有效成分:

Marbofloxacin

可用日期:

LIVISTO Int'l, S.L.

ATC代码:

QJ01MA93

INN（国际名称）:

Marbofloxacin

剂量:

20 mg/tablet

药物剂型:

Tablet

处方类型:

POM: Prescription Only Medicine as defined in relevant national legislation

治疗组:

Cats, Dogs

治疗领域:

marbofloxacin

疗效迹象:

Antibacterial

授权状态:

Authorised

授权日期:

2017-02-10

产品特点

Health Products Regulatory Authority
03 December 2021
CRN00CDSL
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Boflox flavour 20 mg tablets for dogs and cats
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains:
ACTIVE SUBSTANCE:
Marbofloxacin 20mg
EXCIPIENTS:
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Tablet.
Round beige cross-snap tablets with brown speckles.
The tablets can be divided into halves or quarters.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs, cats.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of infections caused by strains of microorganisms
susceptible to marbofloxacin. Please see section 5.1.
In dogs:
• skin and soft tissue infections (skinfold pyoderma, impetigo,
folliculitis, furunculosis, cellulitis)
• urinary tract infections (UTI) associated or not with prostatitis
or epididymitis
• respiratory tract infections.
In cats:
• skin and soft tissue infections (wounds, abscesses, phlegmons)
• upper respiratory tract infections.
4.3 CONTRAINDICATIONS
Marbofloxacin should not be used in dogs aged less than 12 months, or
less than 18 months for exceptionally large breeds of
dogs, such as Great Dane, Briard, Bernese, Bouvier and Mastiff, with a
longer growth period.
Do not use in cats aged less than 16 weeks.
Do not use in cases of hypersensitivity to fluoroquinolones or any of
the excipients of the product.
Do not use in cases of resistance against quinolones, since (almost)
complete cross-resistance exists against other
fluoroquinolones.
Not suitable for infections resulting from strict anaerobes, yeast or
fungi.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
A low urinary pH could have an inhibitory effect on the activity of
marbofloxacin.
Pyoderma occurs mostly secondary to an underlying disease, thus, it is
advisable to determine the underlying cause and treat
the animal accordingly.
4.5 SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
Health Products Regulatory Autho